SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions by Bock, Annika J, Nymoen, Dag Andre, MSc, Brenne, Kjersti, MSc, Kærn, Janne, MD, PhD, Davidson, Ben, MD, PhD

Get full text

Mir-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma by Nymoen, Dag Andre, MSc, Slipicevic, Ana, PhD, Holth, Arild, BSc, Emilsen, Elisabeth, MSc, Falkenthal, Thea E. Hetland, MD, PhD, Tropé, Claes G., MD, PhD, Reich, Reuven, PhD, Flørenes, Vivi Ann, PhD, Davidson, Ben, MD, PhD

Get full text

Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance by Hetland, Thea Eline, MD, Nymoen, Dag Andre, MSc, Holth, Arild, BSc, Brusegard, Kjersti, MSc, Flørenes, Vivi Ann, PhD, Kærn, Janne, MD, PhD, Tropé, Claes G., MD, PhD, Davidson, Ben, MD, PhD

Get full text

Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival by Brenne, Kjersti, MSc, Nymoen, Dag André, MSc, Hetland, Thea Eline, MD, Trope', Claes G., MD, PhD, Davidson, Ben, MD, PhD

Get full text

Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions by Yuan, Yuan, MD, Nymoen, Dag André, MSc, Dong, Hiep Phuc, MSc, Bjørang, Ola, MSc, Shih, Ie-Ming, MD, PhD, Low, Philip S., PhD, Trope', Claes G., MD, PhD, Davidson, Ben, MD, PhD

Get full text